551
Views
20
CrossRef citations to date
0
Altmetric
Reviews

Drugs targeting 5-hydroxytryptamine receptors in acute treatments of migraine attacks. A review of new drugs and new administration forms of established drugs

, MD DMSc, , MD, , MD & , MD PhD

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

David B. Clemow, Helen M. Hochstetler, Yan Dong, Paula Hauck, Mario F. P. Peres & Jessica Ailani. (2021) Effect of a change in lasmiditan dose on efficacy and safety in patients with migraine. Postgraduate Medicine 133:4, pages 449-459.
Read now
Bianca Raffaelli, Heike Israel, Lars Neeb & Uwe Reuter. (2017) The safety and efficacy of the 5-HT 1F receptor agonist lasmiditan in the acute treatment of migraine. Expert Opinion on Pharmacotherapy 18:13, pages 1409-1415.
Read now
László Vécsei, Zsófia Majláth, Délia Szok, Anett Csáti & János Tajti. (2015) Drug safety and tolerability in prophylactic migraine treatment. Expert Opinion on Drug Safety 14:5, pages 667-681.
Read now
Maria Adele Giamberardino & Paolo Martelletti. (2015) Emerging drugs for migraine treatment. Expert Opinion on Emerging Drugs 20:1, pages 137-147.
Read now
Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Luisa Fofi & David Della-Morte. (2014) Drugs targeting nitric oxide synthase for migraine treatment. Expert Opinion on Investigational Drugs 23:8, pages 1141-1148.
Read now

Articles from other publishers (15)

Dimos D. Mitsikostas, Christian Waeber, Margarita Sanchez-del-Rio, Bianca Raffaelli, Håkan Ashina, Antoinette Maassen van den Brink, Anna Andreou, Patricia Pozo-Rosich, Alan Rapoport, Messoud Ashina & Michael A. Moskowitz. (2023) The 5-HT1F receptor as the target of ditans in migraine — from bench to bedside. Nature Reviews Neurology 19:8, pages 489-505.
Crossref
Raghavendra Ramachanderan, Stefan Schramm & Bernd Schaefer. (2023) Migraine drugs. ChemTexts 9:2.
Crossref
Giovanna Viticchi, Lorenzo Falsetti, Mauro Silvestrini & Marco Bartolini. (2022) Ditans: a new prospective for the therapy of migraine attack?. Neurological Sciences 43:9, pages 5709-5716.
Crossref
Anna Ferrari & Cecilia Rustichelli. (2021) Rational Use of Lasmiditan for Acute Migraine Treatment in Adults: A Narrative Review. Clinical Therapeutics 43:4, pages 654-670.
Crossref
Peer Tfelt‐Hansen & Karl Messlinger. (2019) Why is the therapeutic effect of acute antimigraine drugs delayed? A review of controlled trials and hypotheses about the delay of effect. British Journal of Clinical Pharmacology 85:11, pages 2487-2498.
Crossref
Daniel Martins. 2019. The Serotonin System. The Serotonin System 203 224 .
Casper Emil Christensen, Frederikke Schelde Andersen, Nita Wienholtz, Alexander Egeberg, Jacob P Thyssen & Messoud Ashina. (2017) The relationship between migraine and rosacea: Systematic review and meta-analysis. Cephalalgia 38:7, pages 1387-1398.
Crossref
Marta Vila-Pueyo. (2018) Targeted 5-HT1F Therapies for Migraine. Neurotherapeutics 15:2, pages 291-303.
Crossref
David W Dodick. (2018) Migraine. The Lancet 391:10127, pages 1315-1330.
Crossref
Claudia Francesca Gasparini, Robert Anthony Smith & Lyn Robyn Griffiths. (2017) Genetic and biochemical changes of the serotonergic system in migraine pathobiology. The Journal of Headache and Pain 18:1.
Crossref
Luciana Maria Silva de Seixas Maia, Angela Amancio-dos-Santos, Paula Catirina Pereira da Silva Germano, Anna Carolina Santos Marinho Falcão, Desirré Duda-de-Oliveira & Rubem Carlos Araújo Guedes. (2017) Do the accelerating actions of tianeptine and l-arginine on cortical spreading depression interact? An electrophysiological analysis in young and adult rats. Neuroscience Letters 650, pages 134-138.
Crossref
Marie Deen, Casper Emil Christensen, Anders Hougaard, Hanne Demant Hansen, Gitte Moos Knudsen & Messoud Ashina. (2016) Serotonergic mechanisms in the migraine brain – a systematic review. Cephalalgia 37:3, pages 251-264.
Crossref
Branca M.A. Silva, Ana Filipa Borges, Cláudia Silva, Jorge F.J. Coelho & Sérgio Simões. (2015) Mucoadhesive oral films: The potential for unmet needs. International Journal of Pharmaceutics 494:1, pages 537-551.
Crossref
János Tajti, Délia Szok, Zsófia Majláth, Bernadett Tuka, Anett Csáti & László Vécsei. (2015) Migraine and neuropeptides. Neuropeptides 52, pages 19-30.
Crossref
Martina Curto, Luana Lionetto, Francesco Fazio, Dimos-Dimitrios Mitsikostas & Paolo Martelletti. (2015) Fathoming the kynurenine pathway in migraine: why understanding the enzymatic cascades is still critically important. Internal and Emergency Medicine 10:4, pages 413-421.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.